AZ Family·54 event signal
FDA requires blindness warning label on GLP-1 drugs
businessGLP
PHOENIX (AZFamily) — The U.S. Food and Drug Administration now requires all weight loss drugs to carry a warning label about a potential increased risk of sudden blindness, according to new guidance from the...
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: FreeNewsAPIRead at AZ Family
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.